Secondary prevention of venous thromboembolic complications. Focus on dabigatrane
Venous thromboembolic complications (VTEC) are a frequent pathology accompanied by high lethality. After VTEC the risk of their recurrence not equivalent for all patients remains. The anticoagulant therapy available currently effectively prevents VTEC increasing a possibility of hemorrhages. This me...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Russo |
| Cyhoeddwyd: |
Remedium Group LTD
2017-12-01
|
| Cyfres: | Амбулаторная хирургия |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.a-surgeon.ru/jour/article/view/88 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
